JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated Drug Discovery were recently awarded a competitive grant that will allow ...

One landmark study published in 2019 indicated that, among the 1,000 most commonly used human cell lines in preclinical drug discovery, 62% were of European descent, 29% were of East Asian descent ...

All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury; Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection ...

With over two decades of experience in CRO services and ten years advancing drug development candidates from TRL3 to TRL5, this close cooperation provides tailored preclinical support, cutting ...

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process. Traditional methods, often relying on in vitro assays or manual manipulation of ...

Breakthroughs in the preclinical phase have now progressed into the business end of drug development. bcg, a consultancy, estimates that about 65 ai-inspired molecules are currently in human ...

Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-006 for Frontotemporal Dementia PR Newswire ORLANDO, Fla. and TAMPA, Fla., June 9, 2025 ...

The development of a state-of-the-art ‘tumour-on-chip’ model has made it possible to faithfully reproduce the complex microenvironment of aggressive pancreatic ductal adenocarcinoma (PDAC).

--Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors that target dysfunctional metabolic pathways, will present preclinical data ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay ...